In situ localization of mitochondrial DNA replication in intact
 mammalian cells by unknown
In Situ Localization of Mitochondrial DNA 
Replication in Intact Mammalian Cells 
Alison F. Davis and David A. Clayton 
Department of Developmental Biology, Beckman Center for Molecular and Genetic Medicine, Stanford University School of 
Medicine, Stanford, California 94305-5427 
Abstract. Nearly all of the known activities required 
for mitochondrial DNA (mtDNA) replication and ex- 
pression are nuclear-encoded gene products, necessitat- 
ing communication between these two physically dis- 
tinct intracellular compartments. A significant amount 
of both general and specific biochemical information 
about mtDNA replication in mammalian cells has been 
known for almost two decades. Early studies achieved 
selective incorporation of the thymidine analog 
5-Bromo-2-deoxy-Uridine (BrdU) into mtDNA of 
thymidine kinase-deficient (TK[-]) cells. We have re- 
visited this approach from a cellular perspective to de- 
termine whether there exist spatiotemporal constraints 
on mtDNA replication. Laser-scanning confocal mi- 
croscopy was used to selectively detect mtDNA synthe- 
sis in situ in cultured mammalian cells using an immu- 
nocytochemical double-labeling approach to visualize 
the incorporation of BrdU into mtDNA of dye-labeled 
mitochondria. In situ detection of BrdU-incorporated 
mtDNA was feasible after a minimum of 1-2 h treat- 
ment with BrdU, consistent with previous biochemical 
studies that determined the time required for comple- 
tion of a round of mtDNA replication. Interestingly, 
the pattern of BrdU incorporation into the mtDNA of 
cultured mammalian cells consistently radiated out- 
ward from a perinuclear position, suggesting that 
mtDNA replication first occurs in the vicinity of nu- 
clear-provided materials. Newly replicated mtDNA 
then appears to rapidly distribute throughout the dy- 
namic cellular mitochondrial network. 
M 
ITOCHONDRIA  are  semiautonomous  organelles 
that have  a  resident  genome  but  rely heavily 
upon the nucleus to encode both proteins and 
nucleic acids for replication and transcription of mitochon- 
drial  DNA  (mtDNA). t  The  important  discovery  that 
mammalian mitochondria have a genetically distinct (from 
the major cellular [soluble])  thymidine kinase (TK)  en- 
zyme (Berk and Clayton, 1973) greatly facilitated quanti- 
tative biochemical studies of mtDNA  replication in cul- 
tured cells. Early studies showed that cell lines could be 
developed that are devoid of the cellular TK (Kit et al., 
1963); however, these TK(-) cell lines still incorporate the 
thymidine analog 5-Bromo-2-deoxy-Uridine (BrdU) into 
mtDNA  (Clayton and Teplitz,  1972; Berk  and  Clayton, 
1973). As a result, the mtDNA in these cells can be labeled 
to a high specific activity to the relative exclusion of nu- 
clear DNA. 
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Past studies also demonstrated that mtDNA synthesis 
can occur at random during the cell cycle, displaying no 
strict phase  specificity as is the case with nuclear DNA 
synthesis (Bogenhagen and Clayton, 1977). In fact, mtDNA 
can be replicated more than once or not at all during the 
cycling of a  given cell population (Flory and Vinograd, 
1973). Yet, mtDNA copy number is maintained remark- 
ably constant through generations of cell growth and divi- 
sion.  Several  other  features  typify mtDNA  replication, 
such as the fact that unlike chromosomal DNA synthesis, 
there does not appear to exist the same extent of repair oc- 
curring  within  the  mitochondrion  (Clayton,  1991),  al- 
though some forms of mtDNA repair do occur in mamma- 
lian cells (Pettepher et al., 1991; LeDoux et al., 1992; Driggers 
et  al.,  1993; Shen  et  al.,  1995).  Synthesis of mtDNA  is 
thought to occur within the mitochondrial matrix (Clay- 
ton, 1991), enlisting organelle-specific replication and tran- 
scription machineries. Accordingly, mtDNA replication is 
insensitive to inhibitors of nuclear DNA replication such 
as aphidicolin, but susceptible to inhibition by compounds 
that have a  minimal effect on nuclear DNA replication, 
such as dideoxycytosine (ddC) and azidothymidine (AZT) 
(Simpson et al.,  1989; Chen et al., 1991; Erikkson et al., 
1995). 
The significant dependence of mitochondria on nuclear- 
provided materials for the maintenance of mtDNA copy 
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cation from a  cellular perspective, to determine whether 
there  might exist spatial constraints upon replication of 
the mitochondrial genome. Indeed, the process of chromo- 
somal DNA replication occurs at specific loci positioned 
throughout the nuclear interior (Nakayasu and Berezney, 
1989). Such an organization suggests that these centers of 
replicative activity might represent either structural enti- 
ties or functional aggregates of replication enzymes and 
their associated cofactors. We were curious to determine 
whether an analogous arrangement might characterize loci 
of mtDNA synthesis. 
Using  antinucleotide antibodies  (Gratzner,  1982)  and 
recently developed mitochondrial labeling techniques (Whit- 
aker  et  al.,  1991),  we  have  used  confocal microscopic 
methodology to similarly analyze the process of mtDNA 
replication in situ in intact mammalian cells. In a manner 
conceptually analogous to early labeling studies, we have 
assessed the incorporation of the thymidine analog BrdU 
into mtDNA of intact cultured mammalian cells whose mi- 
tochondria have  been  specifically labeled  with  a  mem- 
brane potential-sensitive dye, Hence, the subcellular loca- 
tion of newly synthesized mtDNA can be readily visualized 
by virtue of colocalization of BrdU and mitochondria. Our 
results confirm previous biochemical studies with regard 
to  both  qualitative and  quantitative aspects  of mtDNA 
synthesis in mammalian cells. Moreover, we report that in 
several different cell types, the pattern of incorporation of 
BrdU  into mtDNA  radiates  outward from the  nucleus, 
suggesting that replication of the mitochondrial genome 
may in fact occur within a spatial proximity of the nuclear- 
encoded mtDNA replication machinery. 
Materials and Methods 
Cells and Cell Culture Maintenance 
HeLa human cervical carcinoma cells (CCL 2; American Type Culture 
Collection, Rockville, MD) were grown as monolayer cultures in DME 
(GIBCO BRL, Bethesda, MD) containing high glucose, L-glutamine, and 
110 rag]liter sodium pyruvate, and supplemented with 5% FBS (GIBCO 
BRL) and 1.25 ixg/ml gentamycin (Sigma Chemical Co., St. Louis, MO). 
143B  (TK[-])  human  osteosarcoma cells (CRL  8303;  American Type 
Culture  Collection, kindly provided by Dr.  Eric A.  Shoubridge) were 
maintained in DME supplemented with 5% FBS, 1.25 i~g/ml gentamycin, 
50 ixg/ml uridine, and 100 ~g/ml (333 IxM) BrdU (both from United States 
Biochemical Corp., Cleveland, OH). 143B cells containing mtDNA (p+) 
or lacking mtDNA (p°) were cultured under identical conditions. 143B 
cells were cultured in BrdU-free medium for at least 2 wk (2-3 doubling 
times) before BrdU  pulse  labeling and  immunocytochemical analysis. 
PC12  rat  pheochromocytoma cells  (kindly  provided  by  Dr.  Eric  M. 
Shooter) were maintained in DME supplemented with 6% FBS, 6% bo- 
vine serum, t.25 ixg/ml gentamycin, 100 U penicillin G/ml, and IN) ~g/ml 
streptomycin. PCI2 cell cultures were differentiated with NGF (Harlan 
Bioproducts,  Indianapolis,  IN,  generously  provided  by  Dr.  Eric  M. 
Shooter). Briefly, PC12 cells were cultured on poly-L-lysine (1 mg/ml)- 
coated glass coverslips, serum starved for 1-2 h,  and then cultured in 
NGF-containing (10 ng/ml) serum-free medium (with 0.1% filtered BSA) 
for 6--10 d, with NGF treatments every 3 d. 
Enucleation 
Enucleation of HeLa cells was performed as described previously (Pres- 
cott et al., 1971). Briefly, HeLa cells were seeded onto autoclaved 18-mm 
coverslips (VWR Scientific Corp., Media, PA) in 60-ram plastic dishes 
(Becton Dickinson Labware, Lincoln Park, NJ) and grown to ~50-60% 
confiuency. Cells on coverslips were placed face down in 50-ml polypropy- 
lene conical tubes containing 5 ml prewarmed supplemented DME and 
cytochalasin B (10 ixg/ml) (Sigma Chemical Co.). Cells were centrifuged 
at 37°C (in a table-top centrifuge [model GS-6KR; Beckman Instrs., Ful- 
lerton, CA] warmed by prerunning for ,-~1 h) for 40 min at 3,000 g. Cover- 
slips were then placed in 60-mm dishes and allowed to recover in a 37°C 
5% CO2 incubator for 1-3 h, followed by in vivo labeling with BrdU and 
subsequent labeling and immunocytochemical detection steps. 
Ethidium Bromide Staining of mtDNA 
mtDNA in living HeLa cells was labeled as previously described (Hayashi 
et  al.,  1994).  Briefly,  cells  cultured  on  glass  coverslips were  weakly 
trypsinized (1×  trypsin, 2-3 min at room temperature) and then stained 
with ethidium bromide (2 p~g/ml, in supplemented DME)  for 5 min at 
room temperature. Ceils were then washed repeatedly with supplemented 
DME and visualized by microscopy. 
Platelet Preparation 
Human platelets were obtained from peripheral blood by standard meth- 
odologies. Briefly, blood was collected into a heparinized tube and centri- 
fuged for 15  rain  at  ~1,500  rpm in  a  table-top centrifuge to  separate 
plasma from erythrocytes. The plasma and intervening huffy coat were 
collected, and each was analyzed microscopically for cell content. The 
plasma was recentrifuged (3,100 rpm [2,300 g]) for 30 min at 4°C. The ma- 
jority of supernatant was removed, leaving N1  ml  of platelet "pellet." 
Since the cells were not subjected to a ficoll gradient centrifugation, the 
platelet preparation was not completely free of contaminating erythro- 
cytes and lymphocytes. Platelets were then labeled with BrdU (2 h, 37~C) 
and Mitotracker  TM (Molecular Probes, Eugene, OR) and subjected to im- 
munocytochemistry as detailed below. 
BrdU Labeling and Immunocytochemistry 
Monolayers of 143B (TK[-]), HeLa, or PC12 cells were seeded onto au- 
toclaved glass coverslips and cultured in 60-mm plastic dishes in supple- 
mented DME, in the absence or presence of 10-15 I~M BrdU for 1-72 h. 
In some experiments, to inhibit nuclear DNA replication, HeLa cells were 
pretreated with aphidicolin (Sigma Chemical Co.) as follows: a  30-mM 
treatment stock of aphidicolin was prepared in sterile DMSO. Aphidicolin 
was added directly to the existing culture medium in dishes, to a final con- 
centration of 20 p~M (7 Ixg/ml). Cells were pretreated for a minimum of 60 
min with aphidicolin, at which point BrdU was added. Aphidicolin was 
present in the medium throughout the labeling period. 
For experiments with ddC, differentiated PC12 cells were treated con- 
currently with both ddC and BrdU as follows. A  10-raM treatment stock 
of ddC (Sigma Chemical Co.) was prepared, and cells were treated with 
variable concentrations (10 nM-10 p~M) of ddC simultaneously with BrdU 
(15/~M). ddC was present throughout the BrdU labeling period. 
Before fixation, all cells were labeled in vivo with the mitochondrial 
membrane potential-sensitive dye Mitotracker  TM (Whitaker et al., 1991). 
Briefly, ceils were incubated in the presence of the dye (100 nM, diluted in 
supplemented DME) for 15 rain at 37°C, followed by an identical incuba- 
tion in DME, except in the absence of dye. Labeling and all subsequent 
steps were performed in the dark. Cells were then washed twice with PBS, 
pH 7.4.  Cells were first fixed with 4% paraformaldehyde (diluted from 
freshly prepared 20%  paraformaldehyde [Sigma Chemical Co.]) for 10 
rain at 25°C, and then permeabilized with -20°C acetone. Cells were rehy- 
drated for 3 min (25°C) to 20 h (4°C) in PBS. DNA was denatured by incu- 
bation in 2 N HCI at 37°C for 1 h. Acid was neutralized with 100 mM bo- 
rate buffer, pH 8.5, changing the buffer twice over a 10-min period. Ceils 
were then washed with PBS three times over a 10-min period. Both pri- 
mary and secondary antibodies were diluted in PBS supplemented with 
0.1% BSA at the following concentrations: anti-BrdU, 1:50 (monoclonal; 
Boehringer Mannheim Corp., Indianapolis, IN); anti-DNA polymerase % 
1:250 (polyclonal; generously provided by Dr. W.C. Copeland, National 
Institute of Environmental Health Sciences, Research Triangle Park, NC); 
anti-mitochondrial transcription factor A, 1:1,000 (polyclonal);  <FITC>anti- 
mouse IgG, 1:500; <Cy5>anti-rabbit IgG, 1:500. Primary antibody incu- 
bations were performed for 60 min at 25°C, and secondary antibody incu- 
bations were performed for 30 min at 25°C. Cells were washed repeatedly 
between primary and secondary antibody incubations as well as after the 
secondary antibody incubation period. Finally, cells on coverslips were 
mounted onto glass slides with Cytoseal 60 mounting medium (Stephens 
Scientific, Riverdale, N J). Microscopy was performed using a laser-scan- 
The Journal of Cell Biology, Volume 135, 1996  884 ning confocal microscope (model MRC  1000; BioRad  Labs, Hercules, 
CA) equipped with CoMOS imaging software, mtBrdU in "pednuclear'" 
or "peripheral" cellular regions was experimentally defined as follows. In 
143B  (TK[-]) and HeLa cells, perinuclear mtBrdU was defined as that 
which appeared immediately adjacent to the nuclear boundary, and pe- 
ripheral mtBrdU was defined as the remainder of BrdU incorporation 
into mtDNA. In differentiated PC12 cells, classification of perinuclear and 
peripheral mtBrdU was defined as the appearance of nuclear-proximal 
(cell body-associated) or neurite/growth cone-associated (for perinuclear 
and peripheral, respectively) mtBrdU. The ratio of subcellular mtBrdU 
pools in PC12 cells was quantitated visually by counting the number of flu- 
orescent sites of BrdU incorporation in each region. Digital images were 
colored and merged using Adobe Photoshop software (Adobe Systems 
Inc.,  Mountain  View, CA).  Experiments were  repeated  at  least three 
times, yielding reproducible results. 
Results 
Detection of mtDNA Replication  In Situ in Intact 
Mammalian Cells 
Previous studies have shown that mammalian cell lines can 
be developed that lack the major cellular TK enzyme that 
catalyzes the phosphorylation of thymidine (or the thymi- 
dine  analog BrdU)  to thymidine  (or BrdU) monophos- 
phate (Kriss and Revesz, 1961). However, cells normally 
contain two genetically distinct TK enzymes, one of which 
functions within mitochondria (Berk and Clayton, 1973). 
Hence, the mtDNA in such cell lines (TK[-]) can be la- 
beled to a high specific activity relative to nuclear DNA 
through the addition of exogenous sources of thymidine 
(or BrdU). 
We emulated previous biochemical labeling studies us- 
ing  TK(-)  cells,  using  recently  developed  immunocy- 
tochemical methods to detect the incorporation of BrdU 
into mtDNA (mtBrdU) in intact mammalian cells (Fig. 1). 
While BrdU incorporation from mtDNA repair cannot be 
distinguished in this assay from BrdU incorporation con- 
sequent to mtDNA replication, repair is unlikely to be so 
extensive as to contribute significantly to the observed in- 
corporation. Newly synthesized mtDNA was  readily de- 
tectable in 143B (TK[-]) human osteosarcoma cells after 
a 2-h pulse of BrdU in vivo (Fig. 1 a, green). Colocalization 
with dye-labeled mitochondria (Fig.  1 b, red) confirmed 
the mitochondrial location of BrdU (Fig. 1 c, merged im- 
age, yellow).  Control experiments with 143B (TK[-]) pO 
cells, which  lack  mtDNA,  revealed no incorporation of 
BrdU into the mitochondria of these cells (Fig. 1, e and g), 
although biochemical experiments revealed that these pO 
cells did have functional TK activity measurable in vitro 
(data not shown). The mtDNA status of 143B (TK[-]) p+ 
or p° cells is also indicated by the presence or absence of 
mtTFA, (blue in Fig. 1, d and h, respectively), mtTFA, a 
protein whose presence closely mirrors the mtDNA status 
of the cell, is not detectable in cells that have been either 
transiently or chronically depleted of mtDNA (Larsson et 
al., 1994; Poulton et al., 1994; Davis et al., 1996). 
The  absence  of  a  functional  cellular  TK  enzyme  in 
TK(-) cells permits the exclusive detection of mtBrdU in 
these cells. Since cells typically contain both TK enzymes, 
we  tested  whether  or  not  mtBrdU  was  detectable  in 
TK(+) cells by similar means. Since mtDNA constitutes 
< 1% of cellular DNA, in TK(+) cells nuclear BrdU incor- 
poration far exceeds that of mtDNA. Although both nu- 
clear and mtDNA replication are occurring in these cells, 
the  anti-BrdU  antibody  is  presumably  saturated  under 
normal circumstances of nuclear DNA labeling, and only 
nuclear BrdU could be visualized (Fig. 2 a). However, we 
observed that mtBrdU was readily detectable in these rap- 
idly  dividing  cells  under  circumstances  where  nuclear 
DNA replication was pharmacologically inhibited by pre- 
treatment  with  aphidicolin,  a  compound  that  inhibits 
DNA polymerase ot but not mtDNA polymerase ",/(Fig. 2 
b).  Hence,  the  conditions  required  for  observation  of 
mtBrdU in these TK(+) cells may explain why most re- 
ports measuring cell proliferation with anti-BrdU immu- 
nocytochemistry fail  to  detect  BrdU  incorporation into 
mtDNA. 
Interestingly, we observed that in either 143B (TK[-]) 
or HeLa cells, newly synthesized mtDNA appeared to be 
manifest at a perinuclear location (yellow signal adjacent 
to the nuclear boundary). MtBrdU was not evident in pe- 
ripheral regions of the cell (yellow mtBrdU signal in mito- 
chondria  situated  within  peripheral  cytoplasm)  in  the 
concomitant absence of a perinuclear mtBrdU signal, sug- 
gesting that  perhaps mtDNA  synthesis first occurs near 
the proximity of the nucleus. The results obtained from 
this  microscopic analysis  suggest  that  initial  labeling  of 
mtDNA  might  be  preferentially perinuclear,  becoming 
more broadly distributed toward the periphery of the cell 
upon longer labeling. 
Importantly, the distribution of newly replicated mtDNA 
differs markedly from that of total mtDNA in the cell as 
assessed with vital staining of mtDNA in living cells with 
ethidium bromide (Hayashi et al., 1994) (Fig. 2, d and e). 
Presumably,  the  ethidium  bromide  staining  pattern  ob- 
served solely reflects mtDNA, although a contribution by 
mtrRNA cannot be eliminated. Unfortunately, unlike the 
case with yeast, mammalian mtDNA is refractory to stain- 
ing by conventional means, such as with the DNA-specific 
dye 4', 6-diamino-2-phenylindole (DAPI)  (Russell et al., 
1975). 
IntraceUular Localization  of BrdU Incorporation 
into mtDNA 
As a test of the hypothesis that proximity to the nucleus is 
important for the execution of mtDNA synthesis, we next 
decided to determine whether or not cells could incorpo- 
rate BrdU into mtDNA in the absence of a nucleus, i.e., in 
enucleated cells. We predicted that if the nucleus were re- 
moved, this  function would  no  longer be  supplied,  and 
replication of the mitochondrial genome would cease. 
Using cytochalasin B, HeLa cells were enucleated (Pres- 
cott et al., 1971) and then labeled in vivo with BrdU. Inter- 
estingly, we found that under no circumstances was BrdU 
incorporated into mitochondria of enucleated cells, even 
with relatively long BrdU labeling times, which typically 
resulted in robust levels of mtBrdU. Although a represen- 
tative example of such experiments is shown, results were 
consistent over four separate experiments in which at least 
20 enucleated cells were  analyzed,  mtDNA  synthesis in 
enucleated HeLa cells was not detectable either without 
or with aphidicolin pretreatment (arrowheads in Fig. 3, a 
and c, respectively). Note that the mitochondria in enucle- 
ated  cells  appear reasonably normal  since they retain  a 
Davis and Clayton MtDNA Replication  hz Situ  885 Figure 1.  Immunocytochemical  detection of newly replicated mtDNA in 143B (TK[-]) cells. 143B (TK[-]) cells were analyzed by dou- 
ble-label confocal microscopy as described in Materials and Methods. (a-d) 143B (TK[-]) p+ cells; (e-h) 143B (TK[-]) p° cells. Cells la- 
beled in vivo with BrdU (10 ixM, 2 h) and then stained with anti-BrdU (a and e, green), anti-mtTFA (d and h, blue), or labeled with Mi- 
totracker  TM (b and f, red) are shown, as are BrdU-Mitotracker  TM merged images (c and g, colocalization appearing yellow). 
The Journal  of Cell Biology, Volume 135, 1996  886 Figure 2.  Immunocytochemical detection of BrdU incorporation into mtDNA as a result of aphidicolin pretreatment. Either HeLa or 
143B (TK[-]) cells were labeled in vivo with BrdU (1 or 10 txM, respectively)  and analyzed by double-label confocal microscopy as de- 
scribed in Materials and Methods.  In a-c, all images have been merged; incorporation of BrdU into mtDNA appears yellow, and incor- 
poration of BrdU into nuclear DNA appears green. (a) Untreated HeLa cells labeled in vivo with BrdU (1 h); (b) HeLa cells pretreated 
with aphidicolin  for 1 h before BrdU labeling in vivo (2 h); (c) pattern of BrdU incorporation into mtDNA of 143B (TK[-]) cells la- 
beled with BrdU for 2 h. (d and e) Ethidium bromide vital staining (see Materials  and Methods)  of mtDNA in living HeLa cells (d, fluo- 
rescent image; e, fluorescent image overlaid onto Nomarski DIC image). 
membrane potential (Fig. 3, a  and c, red) and other mito- 
chondrial  components  such  as  mtTFA  (Fig.  3,  b  and  d, 
blue). Also note that the enucleation procedure was never 
complete throughout the entire cell population; however, 
this permitted an internal positive control for both nuclear 
DNA and mtDNA replication (green and yellow in Fig. 3, 
a and c, respectively). 
Similar results were obtained with human platelets (Fig. 
4), which are anucleate but do contain mitochondria and 
mtDNA (Shuster et al., 1988).  Platelets treated with BrdU 
in  vitro  did  not  incorporate  BrdU  into  mtDNA;  the 
merged images are red due to labeling with Mitotracker  TM 
but  no incorporation  of BrdU  (Fig.  4, a-c).  Note  that  a 
"contaminating"  lymphocyte  in  the  platelet  preparation 
does incorporate BrdU into mtDNA (yellow signal), serv- 
ing  as  an  internal  positive  control  for  this  experiment. 
Since  lymphocytes  in  the  bloodstream  are  nondividing 
cells, they do not replicate nuclear DNA and are devoid of 
a nuclear BrdU signal. Together, these data indicate that 
the process of enucleation destroys the ability of mtDNA 
to replicate. 
mtDNA Synthesis in Nondividing Differentiated Cells 
To begin to investigate mtDNA replication in situ in dif- 
ferent cell types, we next attempted to visualize mtDNA 
synthesis in situ in differentiated cells. Nondividing, differ- 
entiated cells represent the "physiological" absence of nu- 
clear  DNA  synthesis.  For  these  experiments,  we  chose 
PC12 cells as a model system. The PC12 cell line originates 
from  a  rat  pheochromocytoma  and,  in  the  presence  of 
NGF,  undergoes  differentiation  into  neuronal-like  cells 
that develop extensive processes (neurites) (Fig. 5 A) and 
synthesize  and  secrete  catecholaminergic  neurotransmit- 
ters  such  as  dopamine  and  norepinephrine  (Greene  and 
Tischler, 1976).  The extensive neurite morphology charac- 
teristic of NGF-differentiated PC12 cells provides the op- 
portunity to ascribe more definitively organelles as perinu- 
clear or  peripheral  since  mitochondria  in  distal  neurites 
and growth cones can be hundreds of microns away from 
those in the perinuclear cell body region. Such an arrange- 
ment provides a  quantifiable  experimental paradigm for 
the  measurement of mtBrdU in  each subcellular  region. 
This is in contrast to the situation with 143B (TK[-]) and 
HeLa cells, each characterized by a  comparatively much 
more  limited  cytoplasmic  volume  and  peripheral  mito- 
chondrial distribution, thus rendering only a qualitative as- 
sessment of the positioning of mtBrdU throughout the cell 
in  those  cell types. In addition,  differentiated PC12 cells 
may  serve  as  a  convenient  model  system to  investigate 
some  of the  drug-induced  neuronal  toxicities  that  have 
been associated with the inhibition of mtDNA replication 
(Chert et al., 1991; Keilbaugh et al., 1993). 
Our results with rat PC12 cells were generally consistent 
Davis and Clayton MtDNA Replication In Situ  887 Figure 3.  Lack of mtDNA synthesis in enucleated cells. After enucleation  with cytochalasin B (see Materials  and Methods),  HeLa cells 
were labeled in vivo with BrdU and then analyzed by double- or triple-label  confocal microscopy, as described  in Materials  and Meth- 
ods. (a and b) Untreated HeLa cells labeled in vivo with BrdU (1 g.M, 18 h); (c and d) HeLa cells pretreated with aphidicolin for 1 h be- 
fore BrdU labeling in vivo (1 tzM, 18 h). a, b, and c, d each represent the same field of cells, showing mtBrdU (a and c, yellow), nuclear 
BrdU (c, green), and mtTFA (b and d, blue). In each case, one representative enucleated cell is shown (arrowhead). 
with those obtained with "undifferentiated," rapidly divid- 
ing  mammalian  (human)  cells  (both  143B  (TK[-])  and 
(TK[-]) HeLa). Specifically, we observed that relatively 
short labeling periods (a few hours) resulted in the appear- 
ance of mtBrdU solely in the perinuclear (cell body-asso- 
ciated)  region of differentiated  PC12  cells  (Fig.  5 A,  b). 
With  increasing  times of exposure to  BrdU  in  vivo, mt- 
BrdU became readily apparent in peripheral neurites and 
growth cones, but also persisted at a perinuclear location 
(Fig. 5 A, c and d), our working experimental definitions 
being nuclear-proximal (cell body-associated) or neurite/ 
growth cone-associated, for perinuclear or peripheral, re- 
spectively. Notably, the  ratio  of perinuclear  to periph- 
eral mtBrdU decreased with time (Fig. 5 B). These data 
suggest that,  since  the  fraction of label in  peripheral re- 
gions increases with time, after synthesis newly replicated 
mitochondrial  genomes are then  distributed  to peripher- 
ally situated mitochondria in the cell through the process 
of axonal transport. Thus, these results are also consistent 
with  the  notion  that  mtDNA  synthesis  is  initiated,  and 
most likely completed, in a nuclear-proximal position. 
Since axonal transport of mitochondria is bidirectional 
(Morris and Hollenbeck, 1995), we attempted to perturb 
mtDNA synthesis in progress with the dideoxy chain ter- 
minator ddC to localize more definitively the initial sites 
of mtDNA synthesis. We hypothesized that since increas- 
ing amounts of ddC would progressively interrupt mtDNA 
replication,  incompletely  replicated  mtDNA  molecules 
would be arrested at their site of synthesis and not trans- 
ported  to mitochondria  elsewhere  within  the  cell.  Ch'ain 
terminators like ddC and azidothymidine (AZT) are good 
substrates  (and  thus  inhibitors)  for  certain  polymerases 
like mtDNA polymerase ~ and HIV reverse transcriptase 
(Simpson et al., 1989;  Erikkson et al., 1995), but not oth- 
ers, such as DNA polymerase a, the major nuclear DNA 
polymerase (Copeland et al., 1992). 
NGF-differentiated  PC12  cells  were  treated  with  in- 
creasing concentrations of ddC (10 nM-10 txM),  in the si- 
multaneous presence of a  constant amount of BrdU. For 
clarity,  only mtBrdU  data  obtained  with  untreated  cells 
(BrdU  only)  compared to  500  nM  ddC  (and  BrdU)  are 
shown (Fig. 6 A, a  and b), although a  complete range of 
ddC concentrations was tested. In each case, BrdU with or 
without ddC exposure was 10 h, at which time peripherally 
located mtBrdU is reproducibly manifest (Fig. 5 A, c). In 
control cells, mtBrdU was readily apparent in both perinu- 
clear and  peripheral  regions  of differentiated  PCI2 cells 
(Fig.  6  A,  a,  arrowhead  and  arrows,  respectively). How- 
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thesis  in  anucleate  human 
platelets.  Human  platelets 
were isolated  from peripheral 
blood  (see  Materials  and 
Methods),  labeled  with  BrdU 
and  Mitotracker  TM,  and  then 
analyzed by double-label  con- 
focal microscopy, as described 
in Materials and Methods. All 
images  (a-d)  have  been 
merged. (a-c) Three represen- 
tative  examples  of individual 
platelets.  (d)  "Contaminat- 
ing" lymphocyte present in the 
platelet preparation. 
ever, as the concentration of ddC was increased, a signifi- 
cantly smaller fraction of mtBrdU was detectable in pe- 
ripheral neurites, whereas only slightly less mtBrdU was 
detectable in the cell body region. At high concentrations 
of ddC (500 nM-1  ~M), virtually no mtBrdU was detect- 
able  in  peripheral  mitochondria,  yet  some  perinuclear 
mtBrdU was still apparent (Fig. 6 A, b, arrowhead). The 
proportion  of perinuclear mtBrdU  to  total  mtBrdU  in- 
creased as the concentration of ddC increased (Fig. 6 B), 
as did the ratio of perinuclear to peripheral mtBrdU (Fig. 
6  C).  These data  are consistent with the notion that  in- 
creasing the relative concentration of ddC during mtDNA 
synthesis results in chain termination and thus an arrest of 
mtDNA replication at its site of synthesis within the cell. 
Consequently, presumably there are insufficient levels of 
mtDNA synthesized at the cell body to be transported to 
peripheral organelles. 
Very high concentrations of ddC (10 IxM) almost com- 
pletely halted mtDNA synthesis, yet a few remaining peri- 
nuclear sites were still detectable (data not shown).  Re- 
sults with these high concentrations of ddC are consistent 
with previous studies in cultured PC12 cells, which have 
shown that mtDNA is severely depleted after exposure to 
10 t~M ddC for 3--6 d in vivo (Chert et al., 1991). 
Discussion 
We  have  developed a  procedure for localizing mtDNA 
replication in situ within intact mammalian cells. Visual- 
ization of recently synthesized mtDNA (mtBrdU), which 
we have assessed in this study, offers a unique opportunity 
to identify spatially the initial locus of mtDNA synthesis, 
an issue which in previous work was not addressable. Our 
results are consistent with previous biochemical studies re- 
porting characteristics of mtDNA synthesis in mammals. 
The data obtained and reported here are in good agree- 
ment with the amount of time required for synthesis of the 
mitochondrial genome, as  well as  the  fact that  mtDNA 
synthesis is not linked to nuclear DNA synthesis and may 
occur at any time during the cell cycle. 
Analogous to the case for chromosomal DNA replica- 
tion, we observed that mtDNA synthesis does not appear 
to be random with respect to subcellular position. Perhaps 
the simplest foreseeable scenario would have been that the 
observed pattern  of incorporation of BrdU into mtDNA 
would not differ from that of the general distribution of all 
cellular  mtDNA,  which  is  present  throughout  all  mito- 
chondria in the cell. Several lines of evidence that we have 
presented here support the notion that mtDNA is instead 
preferentially synthesized in the perinuclear region of the 
cell. 
Our observations in several cell types analyzed revealed 
that  newly synthesized mtDNA  is  manifest in  a  perinu- 
clear position. We did not observe the presence of mtBrdU 
in peripherally situated organelles without the coincident 
appearance of mtBrdU at a perinuclear location, although 
the  distinction  between  perinuclear  and  peripheral  or- 
ganelles  was  not  quantifiably distinguishable  in  "small" 
cell types, such as 143B (TK[-]) and HeLa cells. To more 
readily attribute the subcellular location of BrdU incorpo- 
ration into mtDNA  as perinuclear or peripheral, we as- 
sessed mtDNA  replication in  situ  in  NGF-differentiated 
PC12 cells, which are considerably larger and, importantly, 
whose peripheral  cytoplasm consists  of lengthy neurites 
and growth cones. Such an analysis permitted a  quantifi- 
able assessment of the relative ratio of perinuclear to pe- 
ripheral incorporation of BrdU into mtDNA, revealing in- 
deed that  the  relative proportion of peripheral mtBrdU 
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differentiated with NGF as described in Materials  and Methods. Cells  were la- 
beled in vivo with BrdU (15 ixM) for indicated periods of time and then analyzed 
by double-label confocal microscopy, as described in Materials and Methods. (A) 
Merged confocal microscopic images of mtBrdU incorporation into differentiated 
PC12 cells as a function of BrdU labeling time. BrdU incorporation into mtDNA 
appears yellow.  (a) Representative Nomarski DIC image of NGF-differentiated 
PC12 cells; (b) 3 h BrdU; (c) 10 h BrdU; (d) 72 h BrdU. Note that a-d each repre- 
sent a different field of cells. (B) Quantitation of PC12 time course data. Shown is 
the ratio of perinuclear to peripheral  mtBrdU as a function of BrdU labeling time 
(see Materials and Methods). Each point is representative of at least three sepa- 
rate experiments, in which at least  50 cells were visually  scored per experiment. 
Bar: (A) 10 txm. 
increases  with the length of the BrdU labeling period.  In 
agreement with  our own data  (Fig.  2, d  and e),  previous 
studies  have  demonstrated  that  mtDNA  is  distributed 
throughout  the  cell's  complement  of  mitochondrial  or- 
ganelles  (Hevner  and  Wong-Riley,  1991;  Hayashi  et  al., 
1994; for HeLa cells  and neuronal cells,  respectively),  as 
are some components of the replication and transcription 
machineries  such  as  mtDNA  polymerase  ~  and  mtTFA 
(Davis et al., 1996). 
One simple explanation to account for the observed ap- 
pearance  of mtBrdU  in  PC12  cell  neurites  only  at  later 
time  points  of BrdU  exposure  is that  mtDNA is  synthe- 
sized first in the cell body area and then transported to the 
periphery  via  axonal  transport.  Interestingly,  previous 
studies have shown that translation and import of nuclear- 
encoded mitochondrial proteins occur at the cell body re- 
gion (Hevner and Wong-Riley, 1991), but intraorganellar 
processing  of mitochondrial  precursor  proteins  can  also 
occur in peripheral dendrites and axon terminals (Liu and 
Wong-Riley,  1994).  Perhaps  the  latter  represents  one 
mechanism to provide flexibility with  regard  to local en- 
ergy demand throughout large neurons. Although certain 
compounds such as acrylamide  and colchicine have been 
reported to inhibit axonal transport (Sjrstrand et al., 1970; 
The Journal of Cell Biology, Volume 135, 1996  890 Figure 6.  Effects of ddC on mtDNA synthesis in differentiated PC12 cells. Cells were labeled simultaneously in vivo for 10 h with BrdU 
(15 I~M) and increasing concentrations of ddC and then analyzed by double-label confocal microscopy, as described in Materials and 
Methods. (A) Merged confocal microscopic images of mtBrdU incorporation into differentiated PC12 cells as a function of ddC concen- 
tration, BrdU incorporation into mtDNA appears yellow. (a) Control (no ddC); (b) 500 nM ddC. Perinuclear (cell body-associated) mt- 
BrdU is indicated (arrowheads) as is peripheral (neurite-associated) mtBrdU (arrows). (B and C) Quantitation of PC12 ddC concentra- 
tion-dependency  data.  (B) Shown is the ratio of perinuclear  to total mtBrdU as a function of ddC concentration.  (C) The ratio  of 
perinuclear  to peripheral  mtBrdU as a function of ddC concentration.  Each point is representative  of at least three separate  experi- 
ments. 
Sickles, 1991; Brat and Brimijoin, 1993; Harris et al., 1994), 
experiments  in  which  cells  were  pretreated  with  either 
drug before and throughout several hours of BrdU label- 
ing in vivo proved to be  toxic to the PC12 cell cultures, 
specifically to neurite morphology (data not shown), limit- 
ing the use of these reagents, 
Our experiments with ddC in PC12 cells represent an al- 
ternative strategy to identify initial loci of mtDNA replica- 
tion, since these studies permitted monitoring the arrest of 
mtDNA replication in progress. We observed that increas- 
ing the relative concentration of ddC in vivo resulted in 
the  absence of peripherally situated mtBrdU despite the 
persistence of perinuclear mtBrdU, albeit at reduced lev- 
els. From these data, we propose that high concentrations 
of ddC arrest mtDNA synthesis to the extent that insuffi- 
cient mtDNA levels  are produced, and hence not trans- 
ported, to the cell periphery. Previous data indicate that 
there is a tolerance for the accumulation of mtDNA mole- 
cules  arrested  in  replication  due  to  pyrimidine  dimer- 
induced  blockade  of  strand  elongation  (Clayton  et  al., 
1974). 
Attempts to chase mtBrdU from its initial site of synthe- 
sis  (with  thymidine)  were  uniformly  unsuccessful  with 
PC12 cells  or  any cell  type examined,  with  chase  times 
ranging from 30 min to several hours (data not shown). It 
remains  unclear  why these  experiments  failed,  but  it  is 
possible that the kinetics or lack of cell cycle phase speci- 
ficity of mtDNA synthesis may have played a  role, since 
similar experiments with nuclear BrdU incorporation re- 
vealed that nuclear DNA was successfully chased with thy- 
midine (data not shown). 
Finally, it is possible that the cellular distribution of the 
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ies  with  the  cellular TK  enzyme  revealed  that it is  uni- 
formly distributed throughout the cytoplasm of mamma- 
lian cells in G1- and S-phase (Carozza and Conrad, 1994). 
However, since the purified enzyme or antibodies against 
the mitochondrial protein are not presently available, we 
are unable to address this question directly. Although we 
consider it unlikely that we are assaying the intracellular 
localization of mitochondrial TK, it remains possible (per- 
haps even likely) that some other nuclear-encoded constit- 
uent of the mtDNA replication machinery has a restricted 
localization to the perinuclear region of the cell. 
Our inability  to  detect  mtBrdU  in  enucleated  cells  is 
consistent  with  a  previous  report  which failed  to detect 
any incorporation of [3H]thymidine into enucleated mam- 
malian cells (Follett, 1974), as is our data with physiologi- 
cally enucleated  human platelets  (Fig. 4). Together with 
the remainder of the data presented in this report, these 
results suggest that mtDNA replication first occurs in the 
proximity of the cell nucleus either for convenience, i.e., 
immediate  access  to certain  components  of the nuclear- 
encoded mtDNA  replication machinery, or alternatively, 
that some type of nuclear tethering is required, in which 
some structural entity inherent to the nuclear membrane 
maximizes  the efficiency of transport of newly replicated 
mtDNA  to peripheral regions of the cell. At present, we 
are unable to distinguish between these possibilities. 
In summary, we have successfully detected recently rep- 
licated mtDNA in several cell types, including TK(-) and 
TK(+) cells, as well as in nondividing, differentiated cells 
in culture. One previous ultrastructural study achieved de- 
tection of BrdU incorporation into mitochondria of rat je- 
junal intestinal tissue  (Thiry,  1992); however these  data, 
obtained with electron microscopic methods, did not pre- 
serve the in vivo cellular architecture as we have attempted 
to maintain here. In addition, using immunocytochemical 
detection of BrdU, one study in plants (Nicotiana tabacum) 
has  shown that mtDNA  synthesis  appears  to occur in a 
specific region of the cell, near the quiescent center (Su- 
zuki et al., 1992). However, we believe that our results rep- 
resent the first of such data for mtDNA replication in in- 
tact mammalian cells. 
It is interesting to note that the results reported here are 
consistent  with  earlier  studies  in  amphibian  oocytes,  in 
which the incorporation of [3H]thymidine during the pe- 
riod of mtDNA amplification in early oogenesis preferen- 
tially occurs close to the large oocyte nucleus (Tourte et 
al.,  1984; Mignotte  et  al.,  1987).  Collectively,  these  data 
support an as yet unappreciated topological arrangement 
for replication of the mitochondrial genome in a nuclear- 
proximal  position  that may  play  a  role  in  ensuring that 
only properly replicated  molecules  are  distributed  to all 
cellular mitochondria. 
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